CASQ2 and catecholaminergic polymorphic ventricular tachycardia: It has been known that mutations in CASQ2 lead to catecholaminergic polymorphic ventricular tachycardia (CPVT), which may trigger cardiac arrest (Faggioni et al., 2012).